Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis
Rheumatoid Arthritis Market Expected to More than Double in Value to US$27 Billion by 2015
April 18th, 2008
Research and Markets has announced the addition of "Rheumatoid Arthritis Drug Discoveries: What The Future Holds" to their offering. With significant unmet clinical need and the progressive introduction of higher value and effective biopharmaceuticals, the rheumatoid arthritis market is expected to more than double in value to US$27 billion by 2015. This new management report provides a complete examination of the RA market and its prospects in the medium term. Prevalence and incidence - where in the world' Rheumatoid arthritis is the most common chronic inflammatory joint...
Source: Health Business Week (2008-04-18)
|
